Innovation Medicare Technology 
DAIC
MARCH 20, 2024
1 To qualify for a Breakthrough Device Designation, a device technology must address an unmet need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly debilitating conditions. CLTI is associated with high rates of amputation and mortality as well as high care costs.1
DAIC
APRIL 23, 2024
milla1cf Tue, 04/23/2024 - 16:03 April 23, 2024 — CDL Nuclear Technologies , a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer.
DAIC
JUNE 18, 2024
The designation recognizes the novelty of the technology and the potential to provide a more effective treatment option for patients with coronary artery disease. 3 “We very much appreciate FDA’s breakthrough designation recognition of the bioadaptor technology,” continued Sirhan. Food and Drug Administration (FDA). of the U.S.
DAIC
JUNE 4, 2024
With the rise of digital health, innovative solutions are emerging that can significantly impact patient care and recovery while simultaneously addressing health equity. Technology tools are becoming more sophisticated, bidirectional and disease-specific, and are being designed with home care in mind.
DAIC
MARCH 7, 2024
Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38 Halpern, MD, and Vijay M.
Society of Thoracic Surgeons - Technology
OCTOBER 21, 2021
The linkage also would allow registries to continue providing critical information for approval and coverage of innovative medical interventions and preserve the government’s authority to authorize Medicare Coverage with Evidence Development (CED). Download the PDF version Advocacy Quality Improvement Technology
DAIC
DECEMBER 5, 2024
The company’s advanced non-invasive computed tomography (CT) imaging technology enables comprehensive phenotyping of coronary artery disease, grounded in scientific research based on millions of medical images. We’re proud to be a part of Cleerly’s journey. This is what good software can do in the world!"
Expert insights. Personalized for you.
105 
Let's personalize your content